ArticleCadernos de saude publica2026
[Technological and market analysis of the hemodialysis membranes segment in Brazil based on federal public procurement data].
Article in Cadernos de saude publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study analyzes the market and technology of the hemodialysis membrane segment in Brazil, based on public acquisitions made by the Brazilian Company of Hospital Services (EBSERH, acronym in Portuguese). Kidney failure, which affects about 10% of the world's population, represents a growing challenge for health systems, and Brazil is highly dependent on imports to meet the demand for dialyzers. From August 2022 to July 2023, EBSERH acquired 144,162 dialyzers, from six international manufacturers, evincing the absence of a national production and a great technological dependence on Brazil. Additionally, the physical and transport characteristics of the membranes were evaluated, such as materials used (predominance of polysulfone), dimensions and ultrafiltration coefficient. The results point to the need for robust public policies to foster national production, reducing costs, promoting innovation and strengthening Brazil's technological autonomy. This work provides relevant information for the strategic planning of the hemodialysis sector, identifying gaps and opportunities for the development of a national hemodialysis membrane industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.